Neon Therapeutics, Inc. (NTGN) financial statements (2022 and earlier)

Company profile

Business Address 40 ERIE STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments29,395103,311
Cash and cash equivalents29,39552,700
Short-term investments 50,611
Other undisclosed current assets1,8482,116
Total current assets:31,243105,427
Noncurrent Assets
Operating lease, right-of-use asset7,542
Property, plant and equipment7,1098,205
Other noncurrent assets478456
Total noncurrent assets:15,1298,661
TOTAL ASSETS:46,372114,088
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,16612,690
Accounts payable1,7024,268
Accrued liabilities7,4648,422
Debt1,241 
Total current liabilities:10,40712,690
Noncurrent Liabilities
Long-term debt and lease obligation6,542 
Operating lease, liability6,542
Liabilities, other than long-term debt6149
Other liabilities6149
Total noncurrent liabilities:6,548149
Total liabilities:16,95512,839
Stockholders' equity
Stockholders' equity attributable to parent29,417101,249
Common stock2928
Additional paid in capital282,926275,058
Accumulated other comprehensive loss (75)
Accumulated deficit(253,538)(173,762)
Total stockholders' equity:29,417101,249
TOTAL LIABILITIES AND EQUITY:46,372114,088

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
Operating expenses(81,138)(78,701)
Operating loss:(81,138)(78,701)
Nonoperating income
(Other Nonoperating income)
1,3621,767
Net loss attributable to parent:(79,776)(76,934)
Preferred stock dividends and other adjustments (6,371)
Net loss available to common stockholders, diluted:(79,776)(83,305)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
Net loss:(79,776)(76,934)
Comprehensive loss:(79,776)(76,934)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent75(62)
Comprehensive loss, net of tax, attributable to parent:(79,701)(76,996)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: